Mode of renal replacement therapy determines endotoxemia and neutrophil dysfunction in chronic kidney disease

被引:0
|
作者
Sandra Lemesch
Werner Ribitsch
Gernot Schilcher
Walter Spindelböck
Hildegard Hafner-Gießauf
Gunther Marsche
Lisa Pasterk
Doris Payerl
Bianca Schmerböck
Monika Tawdrous
Alexander R. Rosenkranz
Philipp Stiegler
Gerd Kager
Seth Hallström
Karl Oettl
Katharina Eberhard
Angela Horvath
Bettina Leber
Vanessa Stadlbauer
机构
[1] Medical University of Graz,Department of Internal Medicine, Division of Gastroenterology and Hepatology
[2] Medical University of Graz,Department of Internal Medicine, Clinical Division of Nephrology
[3] Intensive Care Unit,Department of Internal Medicine
[4] Medical University of Graz,Department of Surgery, Division of Transplantation Surgery
[5] Institute of Experimental and Clinical Pharmacology,undefined
[6] Medical University of Graz,undefined
[7] Graz,undefined
[8] Institute of Physiological Chemistry,undefined
[9] Center of Physiological Medicine,undefined
[10] Medical University of Graz,undefined
[11] Medical University of Graz,undefined
[12] Core Facility Computational Bioanalytics,undefined
[13] Center for Medical Research,undefined
[14] Medical University of Graz,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Bacterial infection and sepsis are common complications of chronic kidney disease (CKD). A vicious cycle of increased gut permeability, endotoxemia, inadequate activation of the innate immune system and resulting innate immune dysfunction is hypothesized. We assessed endotoxemia, neutrophil function and its relation to oxidative stress, inflammation and gut permeability in patients with CKD grade 3–5 without renal replacement therapy (CKD group, n = 57), patients with CKD stage 5 undergoing haemodialysis (HD, n = 32) or peritoneal dialysis (PD, n = 28) and patients after kidney transplantation (KT, n = 67) in a cross-sectional observational study. In HD patients, endotoxin serum levels were elevated and neutrophil phagocytic capacity was decreased compared to all other groups. Patients on HD had a significantly higher mortality, due to infections during follow up, compared to PD (p = 0.022). Oxidative stress, neutrophil energy charge, systemic inflammation and gut permeability could not completely explain these differences. Our findings suggest that dialysis modality and not renal function per se determine the development of neutrophil dysfunction and endotoxemia in CKD-patients. HD patients are particularly prone to neutrophil dysfunction and endotoxemia whereas neutrophil function seems to improve after KT. Multi-target approaches are therefore warranted to improve neutrophil function and potentially reduce the rate of infections with patients undergoing haemodialysis.
引用
收藏
相关论文
共 50 条
  • [31] Pulmonary Hemodynamics in Patients with Chronic Kidney Disease before Starting Renal Replacement Therapy
    Bekhit, Fouad
    Baghdady, Yasser
    Hassanin, Noha
    Elfishawi, Huessin
    Said, Karim
    COR ET VASA, 2023, 65 (06) : 837 - 842
  • [32] Predicted risk of renal replacement therapy at arteriovenous fistula referral in chronic kidney disease
    Park, Ken J.
    Benuzillo, Jose G.
    Keast, Erin
    Thorp, Micah L.
    Mosen, David M.
    Johnson, Eric S.
    JOURNAL OF VASCULAR ACCESS, 2021, 22 (03): : 432 - 437
  • [33] New Aspects in the Management of Hypertension in Patients with Chronic Kidney Disease not on Renal Replacement Therapy
    Damianaki, Aikaterini
    Polychronopoulou, Erietta
    Wuerzner, Gregoire
    Burnier, Michel
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2022, 29 (02) : 125 - 135
  • [34] When is a Conservative Approach to Advanced Chronic Kidney Disease Preferable to Renal Replacement Therapy?
    Berger, Joseph R.
    Hedayati, S. Susan
    SEMINARS IN DIALYSIS, 2014, 27 (03) : 253 - 256
  • [35] New Aspects in the Management of Hypertension in Patients with Chronic Kidney Disease not on Renal Replacement Therapy
    Aikaterini Damianaki
    Erietta Polychronopoulou
    Gregoire Wuerzner
    Michel Burnier
    High Blood Pressure & Cardiovascular Prevention, 2022, 29 : 125 - 135
  • [36] Secular trends in kidney disease: is the decreased incidence of renal replacement therapy due to a decrease in chronic kidney disease incidence?
    Thorp, M. L.
    Weinstein, J. R.
    Johnson, E. S.
    Yang, X.
    Smith, D. H.
    CLINICAL NEPHROLOGY, 2008, 70 (03) : 187 - 193
  • [37] Frequency of Fabry disease in chronic kidney disease patients including patients on renal replacement therapy in Korea
    Cho, Eunjung
    Park, Jung Tak
    Yoo, Tae-Hyun
    Kim, Soo Wan
    Park, Cheol Whee
    Han, Seung Seok
    Kim, Yeong Hoon
    Kwon, Young Joo
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2024, 43 (01) : 71 - 81
  • [38] Testosterone Replacement Therapy in Chronic Kidney Disease Patients
    Skiba, Ryszard
    Rymarz, Aleksandra
    Matyjek, Anna
    Dymus, Jolanta
    Wozniak-Kosek, Agnieszka
    Syrylo, Tomasz
    Zielinski, Henryk
    Niemczyk, Stanislaw
    NUTRIENTS, 2022, 14 (16)
  • [39] Use of Procalcitonin in Patients With Various Degrees of Chronic Kidney Disease Including Renal Replacement Therapy
    Grace, Eddie
    Turner, R. Mackenzie
    CLINICAL INFECTIOUS DISEASES, 2014, 59 (12) : 1761 - 1767
  • [40] Associations between plasma lysophospholipids concentrations, chronic kidney disease and the type of renal replacement therapy
    Michalczyk, Anna
    Dolegowska, Barbara
    Heryc, Rafal
    Chlubek, Dariusz
    Safranow, Krzysztof
    LIPIDS IN HEALTH AND DISEASE, 2019, 18 (1)